193 related articles for article (PubMed ID: 21641341)
1. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
Pei Y; Ma P; Wang X; Zhang W; Zhang X; Zheng P; Yan L; Xu Q; Dai G
Eur J Pharmacol; 2011 Sep; 666(1-3):165-72. PubMed ID: 21641341
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
3. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
Li XL; Guan RJ; Xu QH; Wu ZY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
[TBL] [Abstract][Full Text] [Related]
4. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
[TBL] [Abstract][Full Text] [Related]
5. Oxymatrine prevents the development of monocrotaline-induced pulmonary hypertension via regulation of the N
Dai G; Li B; Xu Y; Zeng Z; Yang H
Eur J Pharmacol; 2019 Jan; 842():338-344. PubMed ID: 30419238
[TBL] [Abstract][Full Text] [Related]
6. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
[TBL] [Abstract][Full Text] [Related]
7. Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.
Zheng Z; Yu S; Zhang W; Peng Y; Pu M; Kang T; Zeng J; Yu Y; Li G
Histol Histopathol; 2017 Jan; 32(1):35-41. PubMed ID: 27087006
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
Sun X; Ku DD
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H801-9. PubMed ID: 18055512
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.
Zhou R; Ma P; Xiong A; Xu Y; Wang Y; Xu Q
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957828
[TBL] [Abstract][Full Text] [Related]
10. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
Ou ZJ; Wei W; Huang DD; Luo W; Luo D; Wang ZP; Zhang X; Ou JS
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1131-9. PubMed ID: 20215577
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats.
Zhang W; Zhang J; Liu YK; Liu J; Wang X; Xu Q; Wang Y; Xu X; Dai G
Eur J Pharmacol; 2014 Dec; 745():29-35. PubMed ID: 25310909
[TBL] [Abstract][Full Text] [Related]
13. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
Chen L; Xiao J; Li Y; Ma H
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):1-7. PubMed ID: 21381494
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
[TBL] [Abstract][Full Text] [Related]
16. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
Varshney R; Ali Q; Wu C; Sun Z
Hypertension; 2016 Nov; 68(5):1255-1263. PubMed ID: 27672025
[TBL] [Abstract][Full Text] [Related]
17. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
19. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
Pullamsetti S; Kiss L; Ghofrani HA; Voswinckel R; Haredza P; Klepetko W; Aigner C; Fink L; Muyal JP; Weissmann N; Grimminger F; Seeger W; Schermuly RT
FASEB J; 2005 Jul; 19(9):1175-7. PubMed ID: 15827267
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin alleviates the development of monocrotaline-induced pulmonary hypertension in rats.
Zhang L; Zhang TX; Liu N; Zhang JY; Zhao XY; Zhang H; Shen DL
J Biol Regul Homeost Agents; 2016; 30(3):755-759. PubMed ID: 27655493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
